Role of free radicals in septic shock

Journal of Physiology and Pharmacology

Volumn 48, Issue 4, 1997, Pages 517-527

  Novelli, G P ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Antioxidants; Multiple organ failure; Oxygen free radicals; Septic shock

Indexed keywords

ANTIOXIDANT; COMPLEMENT; CYTOKINE; ENDOTHELIN; FREE RADICAL; NITRIC OXIDE; OXYGEN RADICAL; THROMBOCYTE ACTIVATING FACTOR;

CONFERENCE PAPER; ENDOTOXEMIA; GRANULOCYTE; MACROPHAGE; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; OXYGEN CONSUMPTION; SEPSIS; SEPTIC SHOCK; SPIN TRAPPING;

ANIMALS; FREE RADICALS; HUMANS; REACTIVE OXYGEN SPECIES; SHOCK, SEPTIC;

EID: 0031438451     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (67)

1. Simons RK, Maier R, Lennards ES. Neutrophil function in a rat model of endotoxin-induced lung injury. Arch Surg 1987; 122: 197-203.
2. Jackson SK, Stark JM, Rowlands CC, Evans JC. Electron spin resonance detection of oxygen-centred radicals in murine macrophages stimulated with bacterial endotoxin. Free Rad Biol Med 1989; 7: 165-170.
3. Brackett DJ, Lai EK, Lerner MR, Wilson MF, McCay PB. Spin trapping of free radicals produced "in vivo" in heart and liver during endotoxemis. Free Rad Res Comm 1989; 7: 315-324.
4. Novelli GP. Oxygen radicals in experimental shock: effects of spin-trapping nitrones in ameliorating shock pathophysiology. Crit Care Med 1992; 20: 499-507.
5. Vespasiano MC, Lewandoski JR, Zimmerman JJ. Longitudinal analysis of neutrophil superoxide anion generation in patients with septic shock. Crit Care Med 1993; 81: 666-672.
6. Galley HF, Davies MJ, Webster NR. Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 1996; 24: 1649-1653.
7. Redi H, Gasser H, Hallstrom S, Schlag G. Radical related cell injury. In Pathophysiology of shock, sepsis and organ fuilure, 1993. Springer-Verlag, Berlin Schlag & Redl (ed.) pp. 92-110.
8. Sznaider JI, Fraiman A, Hall JB et al. Increased hydrogen peroxide in the expires breath of patients with acute hypoxemic respiratory failure. Chest 1989; 96: 606-612.
9. Pacht ER, Timerman AP, Lykens MG, Merola AJ. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 1991; 100: 1397-1403.
10. Lykens MG, Davis WB, Pacht ER. Antioxidant activity of bronchoalveolar lavage fluid in the adult respiratory distress syndrome. Lung Cell Mol Physiol 1992; 6: L169-175.
11. Moch M, Schroppel B, Schoenberg MH et al. Protective effects of hydroxyethyl starch-deferoxamine in early sepsis. Shock 1995; 4: 425-432.
12. Ospici P, Cannistraci M, Foschi A et al. Studio sul comportamento della malondialdeide plasmatica e tissutale in soggetti in stato di shock. Acta Anaesth Ital 1983; 34: 867-872.
13. Gangeri G, Sganga G, De Gaetano A et al. Oxygen free radicals damage in sepsis and multiple organ failure: plasma levels of conjugates dienes and endogenous antioxidants. Clin Intensive Care 1992; 3: 16.
14. Kapoor R, Prasad K. Role od polymorphonuclear leukocytes in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion. Free Rad Biol Med 1996; 21: 609-618.
15. Borrelli E, Roux-Lombard P. Grau GE et al. Plasma concentrations of cytokines, their soluble receptors and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24: 392-397.
16. Keen RR, Stella L, Flanigan DP, Lands WE. Differential detection of plasma hydroperoxides in sepsis. Crit Care Med 1991; 19: 1114-1119.
17. Patel JM, Block ER. The role of oxidant gases on membrane fluidity and function in pulmonary endothelil cells. Free Rad Biol Med 1988; 4: 121-134.
18. Poli G, Biasi F, Chiarpotto E et al. Lipid peroxidation in human disease: evidence of red cell oxidative stress after circulatory shock. Free Rad Biol Med 1989; 6: 167-170.
19. Biasi F, Chiarpotto E, Lanfranco G et al. Oxidative stress in the development of human ischemic heptitis during circulatory shock. Free Rad Biol Med 1994; 17: 225-233.
20. Leff JA, Parson PE, Day CE. Serum antioxidants as predictors of adult respiratory distress syndrome. Lancet 1993; 341: 777-780.
21. Krser-Staples JA, Kew RR, Webster RO. Ceruloplasmin and transferrin levels are altered in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1992; 145: 1009-1015.
22. Richard C, Lemonnier F, Thibauld M, Auzepy P. Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome. Crit Care Med 1990; 18: 4-9.
23. Quinlan GJ, Lamb NJ, Ewans TW, Gutteridge JMC. Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome. Crit Care Med 1996; 24: 241-146.
24. Novelli GP, Angiolini P, Tani R, Consales G, Bordi L. Phenyl-t-butyl-nitrone is active against traumatic shock in rats. Free Rad Res Comm 1985; 1: 321-327.
25. Novelli GP, Ursini F (eds). Oxygen free radicals in shock. Karger, Basel, 1986.
26. McKechnie K, Furman BL, Parrat JR. Modification by oxygen free radical scavengers of the metabolic and cardiovascular effects of endotoxin infusion in conscious rats. Circulatory Shock 1986; 19: 429-439.
27. Hamburger SA, McCay PB. Endotoxin-induced mortality in rats is reduced by nitrones. Circulatory Shock 1989; 29: 329-334.
28. Hearse DJ, Tosaki A. Free radicals and reperfusion induced arrhythmics: protection by spin traz agent PBN in the rat heart. Circulation Res 1987; 60: 375-383.
29. Bolli R, Patel BS, Jeroudi MD, Lai EK, McCay PB. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin-trap α-phenyl-N-tert-butylnitrone. J Clin Invest 1988; 82: 476-485.
30. Bradamante S, Monti E, Paracchini E, Piccinini F. Protective activity of the spin trap tert-butyl-alpha-phenyl-nitrone (PBN) in reperfused rat heart. J Mol Cell Cardiol 1992; 24: 375-386.
31. Falsini S, Cellai MP, Angiolini P, Cavuta M, Novelli GP. Glutatione ridotto e L-cisteina nello shock endotossinico nel ratto. Min Anest 1994; 60: 413-418.
32. Goris RJA, Boekholtz WKF, Van Bebber IPT, Noytinck JKS, Schillings PHM. Multiple organ failure and sepsis without bacteria. An experimental model. Arch Surg 1986; 121: 897-901.
33. Di Filippo A, Paternostro E, Scardi S, Consalvo M. Insufficienza multipla d'organo sperimentale nel ratto: effetti protettivi del glulatione ridotto. Acta Anaesth Ital 1992; 43: 358-368.
34. Di Filippo A, Scardi S, Consalvo M, Ridolfi N, Pellegrini G, Paternostro E, Novelli GP. L'etano espirato come marker non invasivo della evoluzione della Multiple Organ Dysfunction Syndrome (MODS) sperimentale. Min Anest 1994; 60: 295-303.
35. Demling R, Nayak U, Ikegami K, Lalonde C. Comparison between lung an liver lipid peroxidation and mortality after zymosan peritonitis in the rat. Shock 1994; 2: 222-227.
36. Bitterman H, Aoki N, Lefer AM. Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion shock. Proc Soc Exptl Biol Med 1988; 188: 265-271.
37. Brackett DJ, Lerner MR, Wilson MF. Dimethyl sulfoxides antagonizes hypotensive metabolic and pathologic responses induced by endotoxin. Circulatory Shock 1991; 33: 156-163.
38. Bernards GR. N-acetylcysteine in experiment and clinical acute lung injury. Am J Med 1991; 91 (Suppl 3): 54-59.
39. Spies CD, Reinhart K, Witt, I et al. Influence of n-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Crit Care Med 1994; 22: 1738-1746.
40. Novelli GP, Casali R, Bonizzoli M et al. Aumento della permeabilità capillare provocato dall'endotossina: protezione con antiossidanti e glutatione. Min Anest 1993; 59: 211-216.
41. Suzuki M, Asako H, Kubes P et al. Neutrophil-derived oxidants promote leukocyte adherence in postcapillary venules. Microvasc Res 1991; 42: 125-138.
42. Suffredini AF, Shelhamer JH, Neumann RD, Brenner M, Baltaro RJ, Parrillo JE. Pulmonary and oxygen transport effects of intravenously administered endotoxin in normal humans. Am Rev Resp Dis 1992; 145: 1398-1403.
43. Nieuwenhuijzen GAP, Knapen MFCM, Oyen WJG, Hendriks T, Corstens FHM, Goris RJA. Organ damage is preceded by changes in protein extravasation in an experimental model od multiple organ dysfunction syndrome. Shock 1997; 7: 98-104.
44. Heflin HC, Brigham KL. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest 1981; 68: 1253.
45. Turnage RH, Magee JC, Guice KS, Myers SI, Oldham KT. Complement activation by the hydroxyl radical during intestinal reperfusion. Shock 1994; 2: 445-450.
46. Domenici-Lombardo L, Adembri C, Consalvo M et al. Evolution of endotoxin induced acute lung injury in the rat. Int J Exp Path 1995; 76: 381-390.
47. Jajdacsy-Balla A, Doi EM, Lerner MR et al. Dose-response effect of in vivo administration of endotoxin on polymorphonuclear leukocytes oxidative burst. Shock 1996; 5: 357-361.
48. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557-1558.
49. Schilling JM, Cakmakci M, Battig U, Geroulanos S. A new approach in the treatment of hypotension in human septic shock by N-monomethyl-L-arginine an inhibitor of the nitric oxide synthethase. Intensive Care Med 1993; 19: 227-231.
50. Huribal M, Kumar R, Cunningham ME, Sumpio BE, McMillen MA. Endothelin-stimulated monocyte supernatants enhance neutrophil superoxide production. Shock 1994; 1: 184-187.
51. Meier B, Radeke HH, Selle S et al. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-α. Biochem J 1989; 263: 539-545.
52. Yamauchi N, Watanabe N, Kuriyama H et al. Suppressive effects of intracellular glutathione on hydroxyl radical production induced by tumor necrosis factor. Int J Cancer 1990; 46: 884-888.
53. Lloyd SS, Chang AK, Taylor FB, Janzen EG, McCay PB. Free radicals and septic shock in primates: the role of tumor necrosis factor. Free Rad Biol Med 1993; 14: 223-242.
54. Varani J, Bendelow MJ, Sealey DE et al. Tumor necrosis factor enhances the susceptibility of vascular endothelium to neutrophil mediated killing. Lab Invest 1988; 59: 292-295.
55. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horizon 1995; 3: 2-32.
56. Tiemermann C, Vane J. Inhibition of nitric oxide synthesis reduces the hypothension induced by bacterial lipopolysaccharides in the rat in vivo. Europ J Pharmacol 1990; 182: 591-595.
57. Kilbourn RG, Jubran A, Gross SS. Reversal of endotoxin-mediated shock by N-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172: 1132-1138.
58. Lorente JA, Landin L, De Pablo R, Renes E, Liste D. L-arginine pathway in the sepsis syndrome. Crit Care Med 1993; 21: 1287-1295.
59. Miyajima T, Kotake Y. Skin-trap N-tert-butyl nitrone (PBN) inhibits induction of nitric oxide synthase in endotoxin-induces shock in mice. Biochem Biophys Res Commun 1995; 215: 114-121.
60. Miyajima T, Kotake Y. Optimal time and dosage of phenyl-N-tert-butyl nitrone (PBN) for the inhibition of nitric oxide synthase induction in mice. Free Rad Biol Med 1996; 22: 463-470.
61. Brunelli L, Crow JP, Beckman JS. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia Coli. Arch Biochem Biophys 1995; 316: 327-334.
62. Ishida H, Ichimori K, Hirota Y, Fukahori M, Nakazawa H. Peroxynitrite-induced cardiac myocyte injury. Free Rad Biol Med 1996; 20: 343-350.
63. Rice-Evans CA, Diplock AT. Current status of antioxidant therapy. Free Rad Biol Med 1993; 15: 77-96.
64. Schiller HJ, Reilly PM, Bulkley GB. Antioxidant therapy. Crit Care Med 1993; 21: S92-102.
65. Maxwell SRJ. Prosoects for use of antioxidant therapies. Drugs 1995; 49: 345-361.
66. Aruoma Ol. Characterization of drugs as antioxidant prophylactics. Free Rad Biol Med 1996; 20: 675-705.
67. Aruoma Ol, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide and hypochlorous acid. Free Rad Biol Med 1989; 6: 593-597.